Guidance

Regulatory research dementia workshop conclusions

Outcomes from the first meeting with the regulators of medicine who had met globally to discuss dementia.

Documents

Details

Following a workshop with other international regulators, MHRA has published information on how we continue to support the development of drugs for dementia.

Updates to this page

Published 16 March 2015

Sign up for emails or print this page